We are live on ! Find out more
LABP

Landos Biopharma, Inc. Common Stock
LABP

Delisted

LABP was delisted on the 23rd of May, 2024.

Back to rankings

0 hedge funds and large institutions have $0 invested in Landos Biopharma, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 16 → 0 (-16)

100% less capital invested

Capital invested by funds: $34.9M → $0 (-$34.9M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 16

Holders
–
Holders Change
-16
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$31.9M
2
DAM
Deltec Asset Management
New York
-$1.07M
3
Renaissance Technologies
Renaissance Technologies
New York
-$406K
4
Macquarie Group
Macquarie Group
Australia
-$316K
5
VF
Virtu Financial
New York
-$313K
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
– -$31.9M -1,486,991 Closed
DAM
2
Deltec Asset Management
New York
– -$1.07M -50,000 Closed
Renaissance Technologies
3
Renaissance Technologies
New York
– -$406K -18,890 Closed
Macquarie Group
4
Macquarie Group
Australia
– -$316K -14,718 Closed
VF
5
Virtu Financial
New York
– -$313K -14,537 Closed
Geode Capital Management
6
Geode Capital Management
Massachusetts
– -$271K -12,604 Closed
BMCM
7
Black Maple Capital Management
Wisconsin
– -$223K -10,405 Closed
PCM
8
PenderFund Capital Management
British Columbia, Canada
– -$271K -9,300 Closed
UBS Group
9
UBS Group
Switzerland
– -$87.7K -4,084 Closed
TRCT
10
Tower Research Capital (TRC)
New York
– -$19.2K -896 Closed
Acadian Asset Management
11
Acadian Asset Management
Massachusetts
– -$2K -134 Closed
Royal Bank of Canada
12
Royal Bank of Canada
Ontario, Canada
– -$1K -61 Closed
JP Morgan Chase
13
JP Morgan Chase
New York
– -$1.27K -59 Closed
Morgan Stanley
14
Morgan Stanley
New York
– -$279 -13 Closed
CPG
15
Cornerstone Planning Group
New Jersey
– -$267 -12 Closed
Wells Fargo
16
Wells Fargo
California
– -$215 -10 Closed

LABP Hedge Fund Activity: Q2 2024 in Review

0 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Landos Biopharma, Inc. Common Stock (LABP) for Q2 2024, worth a combined $0 — down 100% from $34.9M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of LABP and 0 opened new positions — a net loss of 16 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Perceptive Advisors, exiting entirely with an estimated $31.9M sold.

  • 0 institutional investors held Landos Biopharma, Inc. Common Stock (LABP) as of Q2 2024, down from 16 in Q1 2024.
  • Funds reported $0 of Landos Biopharma, Inc. Common Stock stock for Q2 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Landos Biopharma, Inc. Common Stock positions in Q2 2024 and 16 closed out, a net change of -16 holders.
  • The largest Landos Biopharma, Inc. Common Stock seller in Q2 2024 was Perceptive Advisors, an estimated $31.9M sold.

Based on aggregated 13F filings for Q2 2024.